Literature DB >> 240771

[B-chain shortening of matrix-bound insulin by pepsin, I:Preparation and properties of bovine des-pentapeptide(B26-30) insulin (suthor's transl)].

H G Gattner.   

Abstract

Insulin was adsorbed to a strongly acidic ion exchanger and incubated with pepsin. The digestion of the matrix-bound insulin was found to be restricted to the cleavage of the peptide bond between phenylalanine-B25 and tyrosine-B26. Factionation of the reaction products was achieved by gel filtrationon Sephadex G-50 at pH 8 where des-pentapeptide(B26-30)-insulin does not aggregate. Another way to purify this compound was ion-exchange chromatography, which was easy due to the loss of one positive charge on the modified insulin. Crystallization could be achieved in a phenol-containing buffer. Des-pentapeptide(B26-30)-insulin was found to be molecularly uniform by electrophoresis at pH 2.2 and 8.6, thin-layer chromatography, performic acid oxidation, end group analysis and amino acid analysis. The CD-spectrum indicated conformational changes compared to insulin. The biological activity was considerably reduced: fat cell assay 20%, blood sugar depression 30%.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240771

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  6 in total

1.  A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human).

Authors:  G P Schwartz; G T Burke; P G Katsoyannis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Inactive conformation of an insulin despite its wild-type sequence.

Authors:  G Kurapkat; E De Wolf; J Grötzinger; A Wollmer
Journal:  Protein Sci       Date:  1997-03       Impact factor: 6.725

3.  An examination of the role of insulin dimerisation and negative cooperativity using the biological properties of the despentapeptide and deshexapeptide insulins.

Authors:  C S Cockram; R H Jones; P H Sonksen; M A Tatnell; S Q Zhu; G Dodson
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

4.  Acute metabolic actions of des-(B27-B30)-insulin and related analogues in adult rats.

Authors:  H Hartmann; J Korf; U Ottmers; W Creutzfeldt
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

5.  Biological activity of des-(B26-B30)-insulinamide and related analogues in rat hepatocyte cultures.

Authors:  H Hartmann; K Oberhaus; R Spahr; D Brandenburg; W Creutzfeldt; I Probst
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

6.  Binding of insulin to bovine liver plasma membrane. Use of insulin analogues modified at the A1 residue.

Authors:  P Rösen; M Simon; H Reinauer
Journal:  Biochem J       Date:  1980-03-15       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.